LEXX READ THE FULL LEXX RESEARCH REPORT Lexaria Bioscience Corporation (NASDAQ:LEXX) reported fiscal first quarter 2025 ...

Snack foods and sweet treats have seen a decline in purchases, as people reach for more nutrient-dense options.

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

Surgery is the gold standard, GLP-1s are all the rage—whether a head-to-head study is needed depends on who you ask.

In comparison, obesity drugs increase GLP-1 by more than 1,000 percent ... but many people can’t access these drugs because ...

Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health ...

Arguing that McDonald's shares should be valued with a 2% CAGR and 8.5% cost of equity, my calculation for MCD projects a fair implied value equal to $202. While the rapid rise of GLP-1 drugs ...

According to a 2025 BGH survey, 96% of employers worry about GLP-1's long-term cost implications. "As employers see increased health and prescription drug costs, they’re looking to meaningfully ...

BUT HE SA Popular GLP-1 medications approved for weight loss ... as well as how they compare to treatments that are already available. There's at least one study underway to try to answer some ...

According to a 2025 BGH survey, 96% of employers worry about GLP-1's long-term cost implications. "As employers see increased health and prescription drug costs, they're looking to meaningfully invest ...